MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$207,898
Net Income
-$2,264,526
Net Profit Margin
-1089.25%
EPS
-$0.9
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Product revenues net of discounts and rebates
207,898
162,092
197,670*
437,602
Cost of revenues
151,100
85,715
-99,916.5*
537,690
Gross profit
56,798
76,377
297,586.5*
-100,088
Research revenues
0
0
-43,224.5*
90,960
Net revenue
56,798
76,377
254,362*
-9,128
Research and development
598,653
281,464
516,664.5*
809,777
General and administrative expenses
1,729,247
1,889,874
1,128,262*
1,506,620
Total operating expenses
2,327,900
2,171,338
1,644,926.5*
2,316,397
Loss from operations
-2,271,102
-2,094,961
-1,390,564.5*
-2,325,525
Interest expense
1,403
1,389
3,411.5*
1,708
Change in fair value of derivative liabilities
5,665
4,567
23,764*
21,103
Other income, net
12,584
10,762
77,211*
31,550
Total interest and other income (expense), net
-
-
97,563.5*
-
Total interest and other income (loss), net
5,516
4,806
-
8,739
Loss from operations before provision for income taxes
-2,265,586
-2,090,155
-1,293,001*
-2,316,786
Provision for income taxes (note 10)
0
0
-2,625*
250
Net loss
-2,265,586
-2,090,155
-1,290,376*
-2,317,036
Net loss noncontrolling interest
-1,060
-941
-293*
-712
Net loss attributed to 60 degrees pharmaceuticals, inc
-2,264,526
-2,089,214
-1,290,083
-2,316,324
Basic EPS
-0.9
-1.28
-1.925
-0.66
Diluted EPS
-0.9
-1.28
-1.925
-0.66
Basic Average Shares
2,653,848
1,725,758
670,211*
3,675,407
Diluted Average Shares
2,653,848
1,725,758
670,211*
3,675,407
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss attributed
to 60 degrees...
-$2,264,526
(-30.62%↓ Y/Y)
Net loss
noncontrolling interest
-$1,060
(11.96%↑ Y/Y)
Net loss
-$2,265,586
(-30.59%↓ Y/Y)
Other income, net
$12,584
(-3.69%↓ Y/Y)
Product revenues net of
discounts and rebates
$207,898
(105.98%↑ Y/Y)
Loss from operations
before provision for...
-$2,265,586
(-30.70%↓ Y/Y)
Total interest and
other income (loss),...
$5,516
(104.29%↑ Y/Y)
Gross profit
$56,798
(11.63%↑ Y/Y)
Change in fair value of
derivative liabilities
$5,665
(-95.97%↓ Y/Y)
Interest expense
$1,403
(14.91%↑ Y/Y)
Cost of revenues
$151,100
(201.89%↑ Y/Y)
Loss from operations
-$2,271,102
(-41.52%↓ Y/Y)
Net revenue
$56,798
(-77.97%↓ Y/Y)
Total operating
expenses
$2,327,900
(24.98%↑ Y/Y)
General and
administrative expenses
$1,729,247
(7.22%↑ Y/Y)
Research and development
$598,653
(139.57%↑ Y/Y)
Buy us a coffee
60 DEGREES PHARMACEUTICALS, INC. (SXTPW)
60 DEGREES PHARMACEUTICALS, INC. (SXTPW)